Investors & Media

ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences

February 6, 2020 at 4:30 PM EST

WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 6, 2020-- ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

  • Guggenheim Healthcare Talks Oncology Day
    February 13th at 3:00 pm Eastern
  • SVB Leerink 9th Annual Global Healthcare Conference
    February 26th at 10:30 am Eastern
  • Cowen 40th Annual Healthcare Conference
    March 2nd at 11:20 am Eastern

A webcast of each presentation will be accessible through the Investors and Media section of the Company's website on Following the live webcast, a replay will be available at the same location.

ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to “target a better now.”

Learn more about who we are, what we do, and how we do it at

Source: ImmunoGen, Inc.

Courtney O’Konek


FTI Consulting
Robert Stanislaro